Related Experiment Video
Updated: May 6, 2026
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
Examining public perceptions of cardiovascular disease risk screening programs in community pharmacies: a
Suha Alharbi1, Reem Almalki2, Shatha Almajnooni2
1Department of Pharmaceutical Practices, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. sskharbi@uqu.edu.sa.
Background:
Cardiovascular diseases (CVDs) are the leading cause of mortality and morbidity in Saudi Arabia. Early identification and management of risk are critical to addressing this burden. Community pharmacies (CPs) offer an accessible setting for proactive screening; however, pharmacy-based CVD initiatives remain underexplored locally despite demonstrated success internationally. Understanding public perspectives is therefore essential to inform service development.
Aim:
To assess the perceptual factors shaping public acceptance of CP-based CVD risk screening services in Saudi Arabia.
Method:
A convergent parallel mixed-methods design was employed, combining an online questionnaire and semi-structured interviews. Quantitative data were analysed descriptively, while qualitative data were examined using framework analysis guided by the Health Belief Model (HBM), a framework used to explain how beliefs influence health behaviours.
Results:
A total of 523 survey responses and 9 interviews were analysed. Most participants were young, educated Saudi nationals, and reported visiting CPs more frequently than general practitioners. Over half expressed confidence in pharmacists' competence to conduct CVD risk screening, and 60% felt comfortable discussing CVD-related concerns. HBM constructs highlighted perceived susceptibility, severity, and self-efficacy as key motivators, with accessibility and convenience serving as important cues to action. However, concerns related to privacy, cost, and staffing limitations remained significant deterrents.
Conclusion:
Public perception of CP-based CVD screening were generally positive, with accessibility, trust in pharmacists, and perceived benefits supporting engagement. However, views regarding suitability were mixed, and concerns related to privacy, cost, and staffing remain important barriers. The Health Belief Model (HBM) provided a useful framework for understanding these motivations and barriers. Addressing these issues is essential for successful implementation.
More Related Videos
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
Related Concept Videos
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:12Analysis of Population Pharmacokinetic Data
01:27Peripheral Artery Disease III: Interprofessional Care